G C Churchill Selected Research

IB1001

5/2023	N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study.
1/2021	A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G C Churchill Research Topics

Disease

1	Nervous System Diseases (Neurological Disorders) 05/2023
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Sandhoff Disease (Sandhoff's Disease) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	AIDS-Related Complex (ARC) 01/2018
1	Mood Disorders (Mood Disorder) 01/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2014

Drug/Important Bio-Agent (IBA)

2	IB1001IBA 05/2023 - 01/2021
1	Amino Acids FDA Link 01/2021
1	acetylleucineIBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	ebselenIBA 01/2018
1	LithiumIBA 01/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	Nerve Growth Factors (Neurotrophins)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2014
1	Glutathione (Reduced Glutathione)IBA 08/2014

Therapy/Procedure

1	Therapeutics 01/2021